LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 25, 2013--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will
release its fourth quarter and year-end 2012 financial results before
the market opens on Thursday, March 14, 2013.
Following the issuance of the press release regarding the financial
results, management will conduct a conference call at 10:00 a.m. (EST)
that morning. The call will be webcast
live over the Internet and can be accessed by logging on to the
"Investors" section of the Synta Pharmaceuticals website, www.syntapharma.com,
prior to the event.
The call can also be accessed by dialing (877) 407-8035 or (201)
689-8035 prior to the start of the call. For those unable to join the
live conference call, a replay will be available from 2:00 p.m. (EST) on
March 14 through midnight (EST) on March 21. To access the replay, dial
(877) 660-6853 or (201) 612-7415 and refer to conference ID 407525. The
webcast also will be archived on the Company's website.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to
extend and enhance the lives of patients with severe medical conditions,
including cancer and chronic inflammatory diseases. Synta has a unique
chemical compound library, an integrated discovery engine, and a diverse
pipeline of clinical- and preclinical-stage drug candidates with
distinct mechanisms of action and novel chemical structures. All Synta
drug candidates were invented by Synta scientists using our compound
library and discovery capabilities. For more information, please visit www.syntapharma.com.
Source: Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7213